Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo

Detalles Bibliográficos
Autores principales: Fujisawa, Toshio, Nakashima, Hideyuki, Joshi, Bharat H, Puri, Raj K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991088/
http://dx.doi.org/10.1186/2051-1426-1-S1-P73
_version_ 1782312380310487040
author Fujisawa, Toshio
Nakashima, Hideyuki
Joshi, Bharat H
Puri, Raj K
author_facet Fujisawa, Toshio
Nakashima, Hideyuki
Joshi, Bharat H
Puri, Raj K
author_sort Fujisawa, Toshio
collection PubMed
description
format Online
Article
Text
id pubmed-3991088
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39910882014-05-01 Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo Fujisawa, Toshio Nakashima, Hideyuki Joshi, Bharat H Puri, Raj K J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991088/ http://dx.doi.org/10.1186/2051-1426-1-S1-P73 Text en Copyright © 2013 Fujisawa et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Fujisawa, Toshio
Nakashima, Hideyuki
Joshi, Bharat H
Puri, Raj K
Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo
title Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo
title_full Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo
title_fullStr Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo
title_full_unstemmed Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo
title_short Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo
title_sort histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to il-13-pe immunotoxin-based cancer therapy by upregulating il-13rα2 expression in vitro and in vivo
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991088/
http://dx.doi.org/10.1186/2051-1426-1-S1-P73
work_keys_str_mv AT fujisawatoshio histonedeacetylaseinhibitiorsenhancesensitivityofmurinesarcomatumorstoil13peimmunotoxinbasedcancertherapybyupregulatingil13ra2expressioninvitroandinvivo
AT nakashimahideyuki histonedeacetylaseinhibitiorsenhancesensitivityofmurinesarcomatumorstoil13peimmunotoxinbasedcancertherapybyupregulatingil13ra2expressioninvitroandinvivo
AT joshibharath histonedeacetylaseinhibitiorsenhancesensitivityofmurinesarcomatumorstoil13peimmunotoxinbasedcancertherapybyupregulatingil13ra2expressioninvitroandinvivo
AT purirajk histonedeacetylaseinhibitiorsenhancesensitivityofmurinesarcomatumorstoil13peimmunotoxinbasedcancertherapybyupregulatingil13ra2expressioninvitroandinvivo

Ejemplares similares